Bank of New York Mellon’s HUMANIGEN, INC. HGEN Stock Holding History

Bank of New York Mellon’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-878,331	Closed	-$134K	–	4470
2023 Q2	$134K	Sell	878,331 -6,102	-0.7%	-$949	﹤0.01%	4053
2023 Q1	$127K	Hold	884,433	–	–	﹤0.01%	4032
2022 Q4	$106K	Buy	884,433 +263,700	+42%	+$38.1K	﹤0.01%	4103
2022 Q3	$112K	Buy	620,733 +599,680	+2,848%	+$323K	﹤0.01%	4177
2022 Q2	$37K	Sell	21,053 -126,468	-86%	-$284K	﹤0.01%	4415
2022 Q1	$444K	Buy	147,521 +3,331	+2%	+$8.91K	﹤0.01%	3784
2021 Q4	$536K	Buy	144,190 +4,113	+3%	+$24.1K	﹤0.01%	3770
2021 Q3	$830K	Buy	140,077 +5,191	+4%	+$72.9K	﹤0.01%	3505
2021 Q2	$2.35M	Buy	134,886 +113,092	+519%	+$2.06M	﹤0.01%	2891
2021 Q1	$416K	Sell	21,794 -2,440	-10%	-$44.5K	﹤0.01%	3789
2020 Q4	$424K	Buy	+24,234	New	+$290K	﹤0.01%	3697

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Bank of New York Mellon's HGEN Position: Q3 2023 in Review

Bank of New York Mellon sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 878,331 shares — an estimated $134K sold.

Bank of New York Mellon first reported a position in HGEN in Q4 2020 and held it in 11 quarters. The position peaked at $2.35M in Q2 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

Bank of New York Mellon reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
Bank of New York Mellon sold 878,331 HUMANIGEN, INC. shares in Q3 2023, an estimated $134K.
Bank of New York Mellon first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 11 quarters.
Bank of New York Mellon's HUMANIGEN, INC. position peaked at $2.35M in Q2 2021.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.